Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 163

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Coenzyme Q10 and vitamin E deficiency in Friedreich’s ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy

Open access
Cooper, J. M., Korlipara, L. V. P., Hart, P. E., Bradley, J. L., Schapira, A. H. V. · 2008 · European Journal of Neurology

Abstract

Background and purpose: A pilot study of high dose coenzyme Q 10 (CoQ 10)/vitamin E therapy in Friedreich’s ataxia (FRDA) patients resulted in significant clinical improvements in most patients. This study investigated the potential for this treatment to modify clinical progression in FRDA in a randomized double blind trial. Methods: Fifty FRDA patients were randomly divided into high or low dose CoQ 10/ vitamin E groups. The change in International Co‐operative Ataxia Ratings Scale (ICARS) was assessed over 2 years as the primary end‐point. A post hoc analysis was made using cross‐sectional data. Results: At baseline serum CoQ 10 and vitamin E levels were significantly decreased in the FRDA patients (P < 0.001). During the trial CoQ 10 and vitamin E levels significantly increased in both groups (P < 0.01). The primary and secondary end‐points were not significantly different between the therapy groups. When compared to cross‐sectional data 49% of all patients demonstrated improved ICARS scores. This responder group had significantly lower baseline serum CoQ 10 levels. Conclusions: A high proportion of FRDA patients have a decreased serum CoQ 10 level which was the best predictor of a positive clinical response to CoQ 10/vitamin E therapy. Low and high dose CoQ 10/vitamin E therapies were equally effective in improving ICARS scores.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1468-1331.2008.02318.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 163

Metadata

Authors
Cooper, J. M., Korlipara, L. V. P., Hart, P. E., Bradley, J. L., & Schapira, A. H. V.
Venue
European Journal of Neurology
Publisher
Wiley
Published
2008-11-12
Volume
15
Issue
12
Pages
1371-1379
ISSN
  • 1351-5101 (ISSN-L)
  • 1468-1331
OpenAlex
W2144515874
Cited by
163
References
2
FWCI
3.85
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Coenzyme Q10 and vitamin E deficiency in Friedreich’s ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy. https://app.cochat.ai/papers/10.1111/j.1468-1331.2008.02318.x
The paper
Cooper, J. M., Korlipara, L. V. P., Hart, P. E., Bradley, J. L., & Schapira, A. H. V. (2008). Coenzyme Q10 and vitamin E deficiency in Friedreich’s ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy. European Journal of Neurology. https://doi.org/10.1111/j.1468-1331.2008.02318.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.